 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MONTREAL, QC / ACCESSWIRE / November 13, 2023 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the 'Company'), a pharmaceutical company offering and researching life-saving medicines in a variety of...

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

No Immediate Effect on Nasdaq Listing or Trading of the Company's Common StockMONTREAL, QC / ACCESSWIRE / September 21, 2023 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the 'Company&quot...

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

We feel now is a pretty good time to analyse Sunshine Biopharma, Inc.'s ( NASDAQ:SBFM ) business as it appears the...

Sunshine Biopharma, Inc.'s (NASDAQ:SBFM) Path To Profitability

MONTREAL, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: SBFM) (the Company), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its quarterly report for the...

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

Sunshine Biopharma reports Q2 results

Aegis started coverage on shares of Sunshine Biopharma (NASDAQ:SBFM  Free Report) in a research note issued to investors on Monday, Marketbeat Ratings reports. The firm issued a buy rating and a $2.60 target price on the stock. Sunshine Biopharma Price Performance SBFM stock opened at $0.53 ...

Sunshine Biopharma (NASDAQ:SBFM) Research Coverage Started at Aegis

NEW YORK, NY / ACCESSWIRE / May 16, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM).About Sunshine Biopharma, Inc.Sunshine Biopharma recently acquired Nora Pharma Inc. and as a result...

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

MONTREAL, May 16, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today closed its previously announced private placement pursuant to a ...

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

Sunshine Biopharma to sell 5.95M units at $0.84 in private placement

MONTREAL, May 12, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced that it entered into a securities purchase agreement with a ...

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product include treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Pointe-Claire, Canada.

Watchers	10,450
52-Wk Low	$0.2053
52-Wk High	$1.40

Market Cap	$6.32M
Volume (M)	121,699.00
52-Wk High	$1.40
52-Wk Low	$0.2053

SBFM Sunshine Biopharma Inc

About

Feed

News

Fundamentals